Evaluating deceleration and acceleration capacities: Implications for predicting adverse outcomes in patients with

Zhiyao Wei1, Jinghan Huang2, Jie Liu3

  • 1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, National Clinical Research Center for Cardiovascular Diseases, Beijing, China; State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

Heart Rhythm
|September 3, 2025
PubMed

Insights

Deceleration capacity (DC) and acceleration capacity (AC) of heart rate predict mortality in hypertrophic cardiomyopathy (HCM) patients. These autonomic markers identify individuals at high risk for adverse outcomes, aiding clinical management.

Area of Science:

  • Cardiology
  • Autonomic Nervous System Function
  • Electrophysiology

Background:

  • Abnormal cardiac autonomic function is common in hypertrophic cardiomyopathy (HCM) but its prognostic implications are unclear.
  • Deceleration capacity (DC) and acceleration capacity (AC) are emerging markers of parasympathetic and sympathetic activity, respectively.
  • Understanding these markers' role in HCM prognosis is crucial for risk stratification.

Purpose of the Study:

  • To investigate whether DC and AC can predict adverse clinical outcomes in patients diagnosed with HCM.
  • To assess the independent predictive value of DC and AC for mortality in this cohort.

Main Methods:

  • A prospective observational cohort study involving 856 unrelated HCM patients.
  • Data collected between 2013 and 2022.
  • Primary outcome: all-cause death; Secondary outcome: cardiovascular death.
  • Cox regression analysis was employed to evaluate associations between variables and outcomes.

Main Results:

  • Over a median follow-up of 3.0 years, 25 all-cause deaths and 17 cardiovascular deaths occurred.
  • Lower DC values were significantly associated with increased risk of all-cause and cardiovascular death (unadjusted HRs > 1.3, P < .05).
  • Adjusted analysis confirmed DC as an independent predictor of all-cause death (aHR = 1.330, P = .010).
  • Higher AC values were linked to increased risk for both endpoints (unadjusted HRs > 1.4, P < .001).
  • The association between AC and all-cause death remained significant after adjustment (aHR = 1.391, P = .002).

Conclusions:

  • Both DC and AC serve as independent predictors of elevated mortality risk in HCM patients.
  • These heart rate variability parameters demonstrate clinical utility as electrophysiological markers.
  • DC and AC can aid in identifying high-risk individuals with HCM for closer monitoring and management.
Abstract

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
37
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
21
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
32
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K